ASCO Plenary Sessions: impact, legacy, future.

Vandross, Andrae; Prasad, Vinay; Mailankody, Sham

Vandross, Andrae; Prasad, Vinay; Mailankody, Sham.

Afiliação

Vandross A; Division of Hematology Oncology, University of California Los Angeles, Los Angeles, CA.
Prasad V; Division of Hematology Oncology/ Knight Cancer Institute/ Oregon Health & Science University, Portland, OR; Department of Public Health and Preventive Medicine/ Oregon Health & Science University, Portland, OR; Senior Scholar in the Center for Health Care Ethics / Oregon Health & Science University, Portland, OR.
Mailankody S; Myeloma Service, Division of Hematologic Oncology, New York, New York; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: prasad@ohsu.edu.

Semin Oncol ; 43(3): 321-6, 2016 06.

Article em En | MEDLINE | ID: mdl-27178681

Assuntos

Antineoplásicos/uso terapêutico; Oncologia; Sociedades Científicas; Congressos como Assunto; Humanos; Guias de Prática Clínica como Assunto

Palavras-chave

ASCO; Breaking abstract; Influence; Medical conferences; Plenary Sessions

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sociedades Científicas / Oncologia / Antineoplásicos Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Semin Oncol Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google